Tunable hydrogels for controlling phenotypic cancer cell states to model breast cancer dormancy and reactivation
Source abstract
Abstract
During metastasis, disseminated tumor cells (DTCs) from the primary tumor infiltrate secondary organs and reside there for varying lengths of time prior to forming new tumors. The time delay between infiltration and active proliferation, known as dormancy, mediates the length of the latency period. DTCs may undergo one of four fates post-infiltration: death, cellular dormancy, dormant micrometastasis, or invasive growth which, is in part, mediated by extracellular matrix (ECM) properties. Recapitulation of these cell states using engineered hydrogels could facilitate the systematic and controlled investigation of the mechanisms by which ECM properties influence DTC fate. Toward this goal, we implemented a set of sixteen hydrogels with systematic variations in chemical (ligand (RGDS) density and enzymatic degradability) and mechanical (elasticity, swelling, mesh size) properties to investigate their influence on the fate of encapsulated metastatic breast cancer cells, MDA-MB-231. Cell viability, apoptosis, proliferation, metabolic activity, and morphological measurements were acquired at five-day intervals over fifteen days in culture. Analysis of the phenotypic metrics indicated the presence of four different cell states that were classified as: (1) high growth, (2) moderate growth, (3) single cell, restricted survival, dormancy, or (4) balanced dormancy. Correlating hydrogel properties with the resultant cancer cell state indicated that ligand (RGDS) density and enzymatic degradability likely had the most influence on cell fate. Furthermore, we demonstrate the ability to reactivate cells from the single cell, dormant state to the high growth state through a dynamic increase in ligand (RGDS) density after forty days in culture. This tunable engineered hydrogel platform offers insight into matrix properties regulating tumor dormancy, and the dormancy-proliferation switch, and may provide future translational benefits toward development of anti-dormancy therapeutic strategies.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Cancer Cells and Metastasis · 3D Printing in Biomedical Research · Cellular Mechanics and Interactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (57)
Show source-provided references
1. Estimated number of prevalent cases of metastatic bone disease in the US adult population10.2147/CLEP.S28339 ↗
2. Comparison of patterns and prognosis among distant metastatic breast cancer patients by age groups: a SEER population-based analysis
3. Estimation of the number of women living with metastatic breast cancer in the United States10.1158/1055-9965.EPI-16-0889 ↗
4. Engineered in vitro models of tumor dormancy and reactivation10.1186/s13036-018-0120-9 ↗
5. Tumor cell dormancy10.1016/j.molonc.2016.09.009 ↗
6. Controversies in clinical cancer dormancy10.1073/pnas.1106613108 ↗
7. Models, mechanisms and clinical evidence for cancer dormancy10.1038/nrc2256 ↗
8. The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy10.1126/scitranslmed.aan3464 ↗
9. Circulating tumor cells in patients with breast cancer dormancy10.1158/1078-0432.CCR-04-1110 ↗
10. Metastasis “systems” biology: how are macro-environmental signals transmitted into microenvironmental cues for disseminated tumor cells?10.1016/j.ceb.2017.06.002 ↗
11. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases10.1016/S0002-9440(10)65628-3 ↗
12. Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency
13. The relationship between dormant cancer cells and their microenvironment
14. Microenvironments dictating tumor cell dormancy
15. Interactions between disseminated tumor cells and bone marrow stromal cells regulate tumor dormancy10.1007/s11914-018-0471-7 ↗
16. Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone10.1126/scitranslmed.aad4059 ↗
17. Bioengineered models to study tumor dormancy10.1186/s13036-018-0137-0 ↗
18. Dual-phase, surface tension-based fabrication method for generation of tumor millibeads10.1021/la500402m ↗
19. Immobilization platform to induce quiescence in dormancy-capable cancer cells10.1142/S2339547817500078 ↗
20. From competency to dormancy: a 3D model to study cancer cells and drug responsiveness10.1186/s12967-016-0798-8 ↗
21. PEG-fibrinogen hydrogels for three-dimensional breast cancer cell culture10.1002/jbm.a.35899 ↗
22. Targeting extracellular matrix stiffness to attenuate disease: from molecular mechanisms to clinical trials10.1126/scitranslmed.aao0475 ↗
23. Targeting dormant cancer10.1038/nm.3120 ↗
24. Targeting dormant micrometastases: rationale, evidence to date and clinical implications10.1177/1758834015624277 ↗
25. Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton10.1158/0008-5472.CAN-07-6849 ↗
26. Metastatic growth from dormant cells induced by a Col-I-enriched fibrotic environment10.1158/0008-5472.CAN-09-2356 ↗
27. Dormancy and growth of metastatic breast cancer cells in a bone-like microenvironment10.1007/s10585-015-9710-9 ↗
28. Reawakening of dormant estrogen-dependent human breast cancer cells by bone marrow stroma secretory senescence10.1186/s12964-018-0259-5 ↗
29. Pradhan · 2019
30. Effects of PEG hydrogel crosslinking density on protein diffusion and encapsulated islet survival and function10.1002/jbm.a.32134 ↗
31. A synthetic matrix with independently tunable biochemistry and mechanical properties to study epithelial morphogenesis and EMT in a lung adenocarcinoma model10.1158/0008-5472.CAN-12-0895 ↗
32. Characterization of the network structure of PEG diacrylate hydrogels formed in the presence of N-vinyl pyrrolidone10.1002/mren.201300166 ↗
33. Effective tuning of ligand incorporation and mechanical properties in visible light photopolymerized poly(ethylene glycol) diacrylate hydrogels dictates cell adhesion and proliferation10.1088/1748-6041/8/2/025001 ↗
34. Encoding hydrogel mechanics via network cross-linking structure10.1021/acsbiomaterials.5b00064 ↗
35. Stiffness of protease sensitive and cell adhesive PEG hydrogels promotes neovascularization in vivo10.1007/s10439-017-1822-8 ↗
36. Mathematical modeling of molecular diffusion through mucus10.1016/j.addr.2008.09.006 ↗
37. Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy
38. A microvascularized tumor-mimetic platform for assessing anti-cancer drug efficacy10.1038/s41598-018-21075-9 ↗
39. Mechanical confinement via a PEG/Collagen interpenetrating network inhibits behavior characteristic of malignant cells in the triple negative breast cancer cell line MDA.MB.23110.1016/j.actbio.2018.07.032 ↗
40. Surviving at a distance: organ-specific metastasis10.1016/j.trecan.2015.07.009 ↗
41. Compositional control of poly(ethylene glycol) hydrogel modulus independent of mesh size10.1002/jbm.a.33109 ↗
42. Design of synthetic extracellular matrices for probing breast cancer cell growth using robust cyctocompatible nucleophilic thiol-yne addition chemistry10.1016/j.biomaterials.2018.04.046 ↗
43. Actin-based cell protrusion in a 3D matrix10.1016/j.tcb.2018.06.003 ↗
44. Filopodia in cell adhesion, 3D migration and cancer cell invasion10.1016/j.ceb.2015.06.007 ↗
45. Physical limits of cell migration: control by ECM space and nuclear deformation and tuning by proteolysis and traction force10.1083/jcb.201210152 ↗
46. A three-dimensional spheroidal cancer model based on PEG-fibrinogen hydrogel microspheres10.1016/j.biomaterials.2016.10.052 ↗
47. An omentum-inspired 3D PEG hydrogel for identifying ECM drivers of drug resistant ovarian cancer
48. A biomaterial screening approach reveals microenvironmental mechanisms of drug resistance10.1039/c7ib00128b ↗
49. Tunable synthetic extracellular matrices to investigate breast cancer response to biophysical and biochemical cues10.1063/1.5064596 ↗
50. Dormancy signatures and metastasis in estrogen receptor positive and negative breast cancer10.1371/journal.pone.0035569 ↗
51. Implantable pre-metastatic niches for the study of the microenvironmental regulation of disseminated human tumour cells10.1038/s41551-018-0307-x ↗
52. Chemical approaches to dynamically modulate the properties of synthetic matrices10.1021/acsmacrolett.8b00808 ↗
53. 3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions10.1016/j.yexcr.2014.01.017 ↗
54. Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells10.1038/ncomms10690 ↗
55. Identification of novel drugs to target dormant micrometastases10.1186/s12885-015-1409-4 ↗
56. Modeling selective elimination of quiescent cancer cells from bone marrow10.1016/j.neo.2015.08.001 ↗
57. Large-Scale gene expression profiling platform for identification of context-dependent drug responses in multicellular tumor spheroids10.1016/j.chembiol.2016.09.013 ↗